Everyday Health on MSN
Retatrutide is a new GLP-1 hit: But is it legal?
Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.
Scientists have discovered natural GLP-1 in joint fluid, which could open up a new treatment option for arthritis.
Pfizer’s GLP-1 weight management treatment Xianweiying is available for ‌pre-order in China, a Reuters check on ‌a local ...
HCM causes the heart muscle to abnormally thicken, making it harder for the heart to pump blood effectively. According to the ...
MedPage Today on MSN
New kink in the link between GLP-1 drugs and cognition
By extending survival, GLP-1 agents may expand the dementia risk period for diabetes patie ...
As many of us know, keeping weight in check can be hard. National data reflect that reality. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact on ...
Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins ...
In a study, people with gene variants in two genes lost slightly more weight on GLP-1 drugs, but threw up more on Zepbound.
Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't ...
Research suggests GLP-1 drugs like Ozempic and Wegovy could double divorce risk, mirroring trends seen in bariatric surgery ...
Adults who use a GLP-1 have lower macronutrient intake than nonusers, according to data that will be presented at the ...
Glucagon-like peptide-1 receptor agonist use is associated with delayed wound healing in patients undergoing abdominal panniculectomy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results